A form of Staph Infection resistant to common antibiotics is popping up everywhere from gyms—to pediatric wards, and a company in California may have developed a critical weapon to fight MRSA.

It’s called Methicillin—Resistant Staphylococcus Auereas; it's a big word--for a big problem in hospitals. A study in the journal of the American Medical Association found more than 94,000 people were diagnosed with MRSA in 2005, and it was linked to more than 18,000 deaths.

This technology may help. Cepheid in Sunnyvale developed a way to identify the exact strain of MRSA in just an hour, instead of waiting the usual three or four days.

CEO, Cepheid, John Bishop said, "You can get the results immediately and that will help them get the most appropriate antibiotic."

That means patients get effective treatment fast.

The rapid test also means hospitals learn right away when a patient may be infectious, and put them in isolation, preventing them from spreading MRSA to others.